Region selected: North America entering business hours. Buyer pain-language researched this run: AI receptionist human handoff, HIPAA compliant AI workflow, healthtech AI governance policy, PHI/ePHI boundary wording, patient engagement escalation rules, vendor-risk questionnaire evidence, BAA/subprocessor evidence, SOC 2 or HITRUST status, security-questionnaire evidence rooms, LLM spend governance and unsafe automation stop list.
Competitors and alternatives buyers already see
Patient access and AI receptionist tools
Assort Health, Hyro, Notable, Luma Health, Artera, Phreesia, Klara, Relatient, Weave, Solutionreach and similar patient-engagement or front-office vendors may help route calls, messages, reminders and intake.
Trust, GRC and FinOps tools
Vanta, Drata, Secureframe, OneTrust, SafeBase, Whistic, Apptio Cloudability, CloudHealth, CloudZero, Vantage, Datadog and native AWS/Azure/GCP cost tools may help evidence security, trust or spend posture.
What AICS must publish to reach top-3/top-5 consideration
- Show the unsafe-automation line: diagnosis, medication, lab interpretation, emergency, billing/coverage, privacy, complaint and unsupported external-claim content must route to humans.
- Make owners visible: every AI workflow should name a clinical/medical, privacy/security, patient-access, billing, finance or executive owner.
- Connect trust evidence to spend evidence: buyers ask both “is this safe?” and “who owns the AI/cloud cost?” in the same procurement motion.
- Keep no-credentials intake clear: first reviews should use redacted exports, approved screenshots and owner notes by default, not credentials, secrets or raw PHI/ePHI.
- Publish proof boundaries: demo/template artifacts must not imply real clients, certifications, HIPAA compliance, SOC 2/HITRUST evidence, rankings, savings, ROI or revenue.
Human-review escalation policy lanes
| Policy lane | Escalate when... | Owner | Evidence to prepare |
|---|---|---|---|
| Clinical/medical content | A message asks for diagnosis, medication, test-result interpretation, treatment or urgent symptom guidance. | Clinical or medical governance owner | Approved admin-only scope, blocked-topic list and clinical handoff route. |
| PHI/ePHI and vendor use | Raw patient identifiers, chart notes, insurance details or referral attachments may leave approved systems. | Privacy/security owner | Data-category register, retention notes, vendor terms and BAA/subprocessor question list. |
| Billing, coverage and prior auth | A workflow could promise coverage, cost, coding, payer approval or authorization status. | Billing or revenue-cycle owner | Approved scripts, payer limitation wording and escalation queue. |
| External claims | Marketing or sales wants to claim compliance, accuracy, safety, wait-time, patient satisfaction, savings, ROI or ranking. | Executive sponsor plus marketing owner | Approved claim register with source, date, owner and limitation wording. |
How this fits the AICS proof cluster
This page strengthens the existing North America healthtech evidence room by adding a concrete policy artifact buyers can review before a diagnostic. Pair it with the AI cloud FinOps trust evidence room, no-credentials intake policy, first-review checklist, procurement questionnaire owner handoff and HIPAA + AI procurement evidence source map.
Claim boundary
This is a template and buyer-education artifact. It is not production data, not patient data, not PHI/ePHI, not customer data, not a real healthtech case study, not a testimonial, not procurement-win evidence, not HIPAA compliance proof, not SOC 2 proof, not HITRUST certification evidence, not legal advice, not privacy advice, not security advice, not audit advice, not procurement advice, not clinical advice, not medical advice, not billing advice, not savings evidence, not ROI evidence, not ranking evidence, not buyer approval evidence and not revenue evidence. No outreach was sent.